← Journal search
JOURNAL PROFILE
Download details (PDF) ↓

Advanced Drug Delivery Reviews (ISSN 0169-409X, 1872-8294) is a journal published by Elsevier in the Netherlands. It covers Pharmacology, Toxicology and Pharmaceutics and Pharmaceutical Science. It is indexed in Scopus, Web of Science, MEDLINE, PubMed and HEC. Recorded metrics: impact factor 21, Scopus Q1, Web of Science Q1, CiteScore 39 and HEC W-Category. Article processing charge: USD 5,470.

Journal title

Advanced Drug Delivery Reviews

ISSN
0169-409X, 1872-8294
Subject area
PharmacologyToxicology and PharmaceuticsPharmaceutical Science
Indexed
ScopusWeb of ScienceMEDLINEPubMedHEC
Scopus Quartile
Q1
WoS Quartile
Q1
Impact Factor
21
Country
Netherlands
Publisher
Elsevier
SJR
4.015
Open access
No
APC (USD)
5470
About the journal
The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery. In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues. Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution. Theme issues are commissioned by one of the Executive Editors or the Editor-in-Chief. The Journal does not publish stand alone manuscripts. If you wish to submit a theme issue topic for consideration, please contact one of the editors.
Aims and Scope
The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery. In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues. Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution. Theme issues are commissioned by one of the Executive Editors or the Editor-in-Chief. The Journal does not publish stand alone manuscripts. If you wish to submit a theme issue topic for consideration, please contact one of the editors.
SCImago Ranking
435
HEC
W-Category
Journal Website
www.sciencedirect.com/science/journal/0169409X ↗
Registered In
1987
Instructions for Authors URL
www.sciencedirect.com/journal/advanced-drug-delivery-reviews/publish/guide-for-authors ↗
Average Time To Publication After Submission (In Weeks)
—
APC Information URL
www.sciencedirect.com/science/journal/0169409X/publish/open-access-options ↗
Waiver policy
—
WoS Status
Science Citation Index Expanded (SCIE)
Scopus URL
www.scopus.com/sourceid/19409 ↗
Scopus Cite Score
39

Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.

Quick answers about Advanced Drug Delivery Reviews

Is Advanced Drug Delivery Reviews HEC recognised?

Yes. The catalogue records Advanced Drug Delivery Reviews in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.

Is Advanced Drug Delivery Reviews indexed in Scopus?

Yes. Advanced Drug Delivery Reviews is listed as Scopus-indexed, in quartile Q1, with a CiteScore of 39. Check its current status on the Scopus Sources page.

Is Advanced Drug Delivery Reviews in Web of Science?

Yes. Advanced Drug Delivery Reviews is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q1. Confirm on Clarivate's Master Journal List.

What is the impact factor of Advanced Drug Delivery Reviews?

The recorded journal impact factor of Advanced Drug Delivery Reviews is 21. Clarivate updates impact factors every year in Journal Citation Reports.

Is Advanced Drug Delivery Reviews open access, and what does it charge?

Advanced Drug Delivery Reviews is not recorded as fully open access and its APC is USD 5,470. Fees change, so check the journal's website before you submit.

Who publishes Advanced Drug Delivery Reviews?

Advanced Drug Delivery Reviews is published by Elsevier in Netherlands, under ISSN 0169-409X and 1872-8294.

Browse similar journals

Find Journal